ArticleFrontiers in pharmacology2026
Pharmaceutical profile and prescribing practices in compounding pharmacies in Brazil: a cross-sectional study.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The industrialization expanded drug access but standardized formulations often fail to meet individual clinical specificities. Compounding pharmacies fill this gap by providing personalized therapies. In Brazil, although Federal Pharmacy Council Resolutions grant pharmacists the autonomy to prescribe over-the-counter drugs and compounded formulations, this clinical practice faces legal instability and structural challenges. This study aimed to outline the profile of pharmacists and analyze the clinical practice of pharmaceutical prescribing in compounding pharmacies across Brazil. Methods: This is a quantitative, descriptive, and cross-sectional study conducted through an online survey covering all 27 federal units in Brazil. The questionnaire was distributed between May and December of 2024 via institutional channels and professional social networks. The sample consisted of 186 licensed pharmacists working in the compounding sector. Data collection addressed personal and professional information, prescription practices, and the management of self-limiting health problems. Results: The sample was predominantly female (78.5%), with a high concentration in the Southeast region (35%). While 73.1% of participants perform pharmaceutical prescribing, only 43.4% document these prescriptions according to regulatory requirements. Furthermore, 44.3% of participants reported never having taken training courses related to prescribing. The most frequently managed health demands included mild insomnia (86.6%), weight loss (84.4%), and anxiety (83.9%). Herbal medicines were the most prescribed class (87.7%), with Discussion: Pharmacists in Brazilian compounding pharmacies actively perform clinical prescribing, primarily managing self-limiting conditions with herbal and nutritional therapies. However, a significant gap persists between practice and formalization, characterized by low documentation rates, lack of infrastructure privacy, and training deficiencies. Addressing these regulatory, educational, and structural limitations is critical to ensuring patient safety, establishing clinical governance, and consolidating the role of the compounding pharmacist in the healthcare system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.